Market revenue in 2023 | USD 4.5 million |
Market revenue in 2030 | USD 6.1 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Ck |
Fastest growing segment | CRP |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Ck was the largest segment with a revenue share of 17.78% in 2023. Horizon Databook has segmented the Chile blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Chile, there is a growing focus on enhancing sports infrastructure and increasing participation across the country. Over the past decade, the Chilean State has consistently invested in the sports sector, allocating an annual average of over USD 140.8 million to its national sports budget. Between 2009 and 2018, this budget increased in 5 years, reflecting the government’s commitment to developing sports facilities and programs.
As sports participation rises, there is a corresponding demand for advanced medical technologies, particularly in sports medicine. This growth aligns with the country’s broader investment in sports, ensuring that athletes receive top-tier medical care and support, enhancing their performance and overall well-being.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account